Tegoprazan-Amoxicillin Dual Therapy Versus Bismuth Quadruple Therapy Versus Tegoprazan-Based Quadruple Therapy for Helicobacter pylori Eradication: A Network Meta-Analysis.

Cureus · 2026 · PMC13172645 · PMID 42147649

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The RR for BQT versus TADT was 0.82 (95% CI: 0.53-1.28), indicating that BQT was numerically associated with a lower probability of eradication; however, this difference did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.